AU5465190A

AU5465190A – Nucleic acid encoding the alpha or beta chains of inhibin and method for synthesizing polypeptides using such nucleic acid
– Google Patents

AU5465190A – Nucleic acid encoding the alpha or beta chains of inhibin and method for synthesizing polypeptides using such nucleic acid
– Google Patents
Nucleic acid encoding the alpha or beta chains of inhibin and method for synthesizing polypeptides using such nucleic acid

Info

Publication number
AU5465190A

AU5465190A
AU54651/90A
AU5465190A
AU5465190A
AU 5465190 A
AU5465190 A
AU 5465190A
AU 54651/90 A
AU54651/90 A
AU 54651/90A
AU 5465190 A
AU5465190 A
AU 5465190A
AU 5465190 A
AU5465190 A
AU 5465190A
Authority
AU
Australia
Prior art keywords
nucleic acid
alpha
inhibin
beta chains
synthesizing polypeptides
Prior art date
1985-10-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Application number
AU54651/90A
Inventor
Anthony John Mason
Peter Horst Seeburg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Genentech Inc

Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1985-10-03
Filing date
1990-05-03
Publication date
1990-11-29
Family has litigation

First worldwide family litigation filed
litigation
Critical
https://patents.darts-ip.com/?family=27419805&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU5465190(A)
«Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1986-09-12
Priority claimed from US06/906,729
external-priority
patent/US4798885A/en

1990-05-03
Application filed by Genentech Inc
filed
Critical
Genentech Inc

1990-11-29
Publication of AU5465190A
publication
Critical
patent/AU5465190A/en

Status
Abandoned
legal-status
Critical
Current

Links

Espacenet

Global Dossier

Discuss

Classifications

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07K—PEPTIDES

C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans

C07K14/575—Hormones

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K38/00—Medicinal preparations containing peptides

Abstract

DNA encoding the prepro inhibin alpha and beta chains has been isolated. This DNA is ligated into expression vectors and used to transform host cells for the preparation of inhibin or activin. Also provided are prohormone domains and other inhibins alpha or beta chain derivatives having therapeutic or diagnostic interest. The compositions provided herein are useful in the manipulation of fertility in animals.

AU54651/90A
1985-10-03
1990-05-03
Nucleic acid encoding the alpha or beta chains of inhibin and method for synthesizing polypeptides using such nucleic acid

Abandoned

AU5465190A
(en)

Applications Claiming Priority (6)

Application Number
Priority Date
Filing Date
Title

US78391085A

1985-10-03
1985-10-03

US783910

1985-10-03

US82771086A

1986-02-07
1986-02-07

US827710

1986-02-07

US06/906,729

US4798885A
(en)

1986-02-07
1986-09-12
Compositions of hormonally active human and porcine inhibin containing an α chain and 62 chain

US906729

1986-09-12

Related Parent Applications (1)

Application Number
Title
Priority Date
Filing Date

AU63512/86A
Division

AU603775B2
(en)

1985-10-03
1986-10-02
Nucleic acid encoding the alpha or beta chains of inhibin and method for synthesizing polypeptides using such nucleic acid

Related Child Applications (1)

Application Number
Title
Priority Date
Filing Date

AU52433/93A
Division

AU5243393A
(en)

1985-10-03
1993-12-15
Nucleic acid encoding the alpha or beta chains of inhibin and method for synthesizing polypeptides using such nucleic acid

Publications (1)

Publication Number
Publication Date

AU5465190A
true

AU5465190A
(en)

1990-11-29

Family
ID=27419805
Family Applications (3)

Application Number
Title
Priority Date
Filing Date

AU63512/86A
Expired

AU603775B2
(en)

1985-10-03
1986-10-02
Nucleic acid encoding the alpha or beta chains of inhibin and method for synthesizing polypeptides using such nucleic acid

AU54651/90A
Abandoned

AU5465190A
(en)

1985-10-03
1990-05-03
Nucleic acid encoding the alpha or beta chains of inhibin and method for synthesizing polypeptides using such nucleic acid

AU52433/93A
Abandoned

AU5243393A
(en)

1985-10-03
1993-12-15
Nucleic acid encoding the alpha or beta chains of inhibin and method for synthesizing polypeptides using such nucleic acid

Family Applications Before (1)

Application Number
Title
Priority Date
Filing Date

AU63512/86A
Expired

AU603775B2
(en)

1985-10-03
1986-10-02
Nucleic acid encoding the alpha or beta chains of inhibin and method for synthesizing polypeptides using such nucleic acid

Family Applications After (1)

Application Number
Title
Priority Date
Filing Date

AU52433/93A
Abandoned

AU5243393A
(en)

1985-10-03
1993-12-15
Nucleic acid encoding the alpha or beta chains of inhibin and method for synthesizing polypeptides using such nucleic acid

Country Status (11)

Country
Link

EP
(1)

EP0222491B2
(en)

AT
(1)

ATE119937T1
(en)

AU
(3)

AU603775B2
(en)

CA
(1)

CA1341631C
(en)

DE
(1)

DE3650267T3
(en)

ES
(1)

ES2072248T5
(en)

HK
(1)

HK1007332A1
(en)

IE
(1)

IE65795B1
(en)

IL
(1)

IL80218A
(en)

LV
(1)

LV11485B
(en)

NZ
(2)

NZ231899A
(en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

AU610821B2
(en)

*

1985-04-18
1991-05-30
Inhibin Pty Limited
Recombinant inhibin

DE3650689T2
(en)

1985-04-18
1999-04-08
Biotech Australia Pty Ltd

RECOMBINANT INHIBIN

JPH0637520B2
(en)

*

1985-07-03
1994-05-18
味の素株式会社

Polypeptide

US4740587A
(en)

*

1985-07-18
1988-04-26
The Salk Institute For Biological Studies
Inhibin and method of purifying same

WO1987005702A1
(en)

*

1986-03-13
1987-09-24
Biotechnology Australia Pty. Ltd.
Method of assay of inhibin

CA1302651C
(en)

*

1986-04-04
1992-06-02
Wylie Walker Vale, Jr.
Fsh-releasing peptide

US4973577A
(en)

*

1986-04-04
1990-11-27
The Salk Institute For Biological Studies
FSH-releasing peptides

US5015729A
(en)

*

1986-06-24
1991-05-14
The Salk Institute For Biological Studies
Ovine inhibin

ATE118351T1
(en)

*

1988-05-31
1995-03-15
Biotech Australia Pty Ltd

EFFECT OF HORMONES.

US5071834A
(en)

*

1988-09-16
1991-12-10
Genentech, Inc.
Purified activin B composition

US4997815A
(en)

*

1988-11-01
1991-03-05
Children’s Hospital Medical Center Of Northern California
Method for augmenting fetal hemoglobin by treatment with activin and/or inhibin

AU7321891A
(en)

*

1990-02-15
1991-09-03
Cetus Corporation
Inhibitor of cytokine activity and applications thereof

IL99867A0
(en)

*

1991-10-27
1992-08-18
Yissum Res Dev Co
Pharmaceutical compositions containing activin a

JP3504263B2
(en)

1991-11-04
2004-03-08
ジェネティックス・インスチチュート・リミテッド・ライアビリティ・カンパニー

Recombinant bone morphogenetic protein heterodimers, compositions and uses

US5807713A
(en)

*

1992-02-12
1998-09-15
Biopharm Gesellschaft Zur Biotechnologischen Entwicklung
DNA encoding growth/differentiation factor

US6120760A
(en)

*

1992-02-12
2000-09-19
Biopharm Gesellschaft Zur Biotechnologischen Entwicklung
Growth/differentiation factors of the TGF-β family

US7067637B1
(en)

1992-02-12
2006-06-27
Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh
Antibody or antibody fragments specific for a protein of the TGF-β family

US7025959B1
(en)

1992-02-12
2006-04-11
Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh
MP121, a growth/differentiation factor of the TGF-β family

US6171584B1
(en)

1992-02-12
2001-01-09
Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh
Method of treatment with growth/differentiation factors of the TGF-β family

US5753612A
(en)

*

1992-10-27
1998-05-19
Yissum Research Development Co. Of The Hebrew University Of Jerusalem
Pharmaceutical composition and method for inhibiting hair growth by administration of activin or activin agonists

PT1378572E
(en)

*

1993-05-12
2007-01-31
Genetics Inst
Bmp-11 compositions

US5658876A
(en)

*

1994-04-28
1997-08-19
The General Hospital Corporation
Activin antagonists as novel contraceptives

FR2720069A1
(en)

*

1994-05-19
1995-11-24
Inst Nat Sante Rech Med
Variants of transforming growth factor-beta proteins

IL114397A0
(en)

*

1994-07-01
1995-10-31
Bioph Biotech Entw Pharm Gmbh
Growth/differentiation factor of the TGF-beta-family

EP1163365A4
(en)

1999-02-25
2002-11-20
Auckland Uniservices Ltd
Diagnosis and therapy of premature ovarian failure

TWI329129B
(en)

2001-02-08
2010-08-21
Wyeth Corp
Modified and stabilized gdf propeptides and uses thereof

AUPR638101A0
(en)

2001-07-13
2001-08-09
Bioa Pty Limited
Composition and method for treatment of disease

PL1675608T3
(en)

2003-09-12
2007-11-30
Wyeth Corp
Injectable calcium phosphate solid rods for delivery of osteogenic proteins

WO2005116052A2
(en)

2004-04-27
2005-12-08
Research Development Foundation
ANTAGONISM OF TGF-β SUPERFAMILY RECEPTOR SIGNALING

TWI610939B
(en)

*

2007-02-21
2018-01-11
腫瘤療法 科學股份有限公司
Peptide vaccines for cancers expressing tumor-associated antigens

TW201008574A
(en)

2008-08-19
2010-03-01
Oncotherapy Science Inc
INHBB epitope peptides and vaccines containing the same

WO2010144696A1
(en)

2009-06-11
2010-12-16
Burnham Institute For Medical Research
Directed differentiation of stem cells

BR102014005376A2
(en)

*

2014-03-07
2016-02-10
Ouro Fino Saúde Animal Ltda

inhibin alpha antigen, inhibin alpha coding gene, fusion protein encoding gene, process of obtaining inhibin alpha antigen, antigenic composition, use of inhibin alpha antigen, and use of antigenic composition

CN108285903B
(en)

*

2018-01-29
2021-03-12
国家卫生计生委科学技术研究所
Preparation method of specific stimulating antigen

Family Cites Families (4)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

CA1341617C
(en)

*

1984-06-08
2011-06-28
Henry George Burger
Inhibin isolated from ovarian follicular fluid

DE3650689T2
(en)

*

1985-04-18
1999-04-08
Biotech Australia Pty Ltd

RECOMBINANT INHIBIN

AU5903986A
(en)

*

1985-04-18
1986-11-05
Biotechnology Australia Proprietary Limited
Recombinant inhibin

AU610821B2
(en)

*

1985-04-18
1991-05-30
Inhibin Pty Limited
Recombinant inhibin

1986

1986-09-29
NZ
NZ231899A
patent/NZ231899A/en
unknown

1986-09-29
NZ
NZ217727A
patent/NZ217727A/en
unknown

1986-10-02
EP
EP86307586A
patent/EP0222491B2/en
not_active
Expired – Lifetime

1986-10-02
IE
IE261886A
patent/IE65795B1/en
not_active
IP Right Cessation

1986-10-02
DE
DE3650267T
patent/DE3650267T3/en
not_active
Expired – Lifetime

1986-10-02
IL
IL8021886A
patent/IL80218A/en
not_active
IP Right Cessation

1986-10-02
ES
ES86307586T
patent/ES2072248T5/en
not_active
Expired – Lifetime

1986-10-02
AT
AT86307586T
patent/ATE119937T1/en
not_active
IP Right Cessation

1986-10-02
AU
AU63512/86A
patent/AU603775B2/en
not_active
Expired

1986-10-03
CA
CA519750A
patent/CA1341631C/en
not_active
Expired – Fee Related

1990

1990-05-03
AU
AU54651/90A
patent/AU5465190A/en
not_active
Abandoned

1993

1993-12-15
AU
AU52433/93A
patent/AU5243393A/en
not_active
Abandoned

1996

1996-03-14
LV
LVP-96-83A
patent/LV11485B/en
unknown

1998

1998-06-25
HK
HK98106550A
patent/HK1007332A1/en
not_active
IP Right Cessation

Also Published As

Publication number
Publication date

AU6351286A
(en)

1987-04-09

AU603775B2
(en)

1990-11-29

DE3650267T2
(en)

1995-10-05

CA1341631C
(en)

2012-06-12

LV11485B
(en)

1996-12-20

EP0222491B1
(en)

1995-03-15

IE862618L
(en)

1987-04-03

EP0222491A1
(en)

1987-05-20

DE3650267D1
(en)

1995-04-20

LV11485A
(en)

1996-08-20

EP0222491B2
(en)

2003-08-13

HK1007332A1
(en)

1999-04-09

AU5243393A
(en)

1994-03-10

ES2072248T5
(en)

2004-05-01

ES2072248T3
(en)

1995-07-16

NZ217727A
(en)

1990-05-28

IE65795B1
(en)

1995-11-15

DE3650267T3
(en)

2004-05-13

NZ231899A
(en)

1991-07-26

ATE119937T1
(en)

1995-04-15

IL80218A
(en)

1994-11-28

Similar Documents

Publication
Publication Date
Title

AU5243393A
(en)

1994-03-10

Nucleic acid encoding the alpha or beta chains of inhibin and method for synthesizing polypeptides using such nucleic acid

AU6329694A
(en)

1994-09-01

Recombinant expression vectors and purification methods for thermus thermophilus DNA polymerase

ATE62485T1
(en)

1991-04-15

INDOLIZINE DERIVATIVES, METHOD OF PREPARATION AND COMPOSITIONS CONTAINING THEM.

GR3018825T3
(en)

1996-04-30

3-Demethyl-4-fluoro-mevalonic-acid derivatives, process for their preparation, pharmaceutical preparations based on those compounds, their use and intermediates

JPS6486896A
(en)

1989-03-31

Method for isolating basic protein from protein mixture containing the basic protein

DK495683A
(en)

1984-04-30

BETA CARBOLINES, METHOD OF PREPARING THE SAME AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME

DK254386A
(en)

1986-12-02

PYRIDINE DERIVATIVES, PROCEDURES FOR THE PREPARATION OF THESE AND PREPARATIONS CONTAINING THESE COMPOUNDS

EP0060491A3
(en)

1983-03-30

Protein pp16, process for concentrating and isolating it, and its use

AU2441188A
(en)

1989-07-13

Heterobifunctional coupling agents

AU6745287A
(en)

1987-07-16

Dna sequences coding for proteins having the biological activity of husi-type i inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins

ATE98643T1
(en)

1994-01-15

ARALKYLAMINALKOXYPHENYL DERIVATIVES, METHOD OF PREPARATION AND COMPOSITIONS CONTAINING THEM.

AU7242687A
(en)

1987-11-19

Nucleic acid and methods for the synthesis of novel DAF compositions

EP0313095A3
(en)

1990-10-24

Method for preparing hydroxysilanes and/or their oligomers

EP0293079A3
(en)

1988-12-14

Chlamydia vaccine

GR3005922T3
(en)

1993-06-07

NO871137D0
(en)

1987-03-19

NON-INFLAMMATIVE HYALURONIC ACID FRACTION AND PROCEDURE FOR PREPARING THIS.

HUT45398A
(en)

1988-07-28

Process for production of lyophilized medical compositions containing derivatives of phenil-quinoline-carbonic acid

ATE41426T1
(en)

1989-04-15

PROCESS FOR THE PREPARATION OF TRIACETOXYSILANES FROM TRIS(AMINO)SILANES.

ZA867569B
(en)

1988-06-29

Nucleic acid encoding the alpha or beta chains of inhibin and method for synthesizing polypeptides using such nucleic acid

EP0285361A3
(en)

1989-11-02

Purification of apase-1 1 and retrieval of the nematode resistance gene

DE233459T1
(en)

1987-12-17

MAGNESIUM-UREA COMPLEX OF THE MEDICINE CONTAINING ACETYLSALICYL ACID AND METHOD FOR PRODUCING THIS COMPLEX.

DE3465239D1
(en)

1987-09-17

Nitrogen source for organisms

JPS6432170A
(en)

1989-02-02

Production of novel fluorescent labeled antibody

NO900261L
(en)

1990-07-20

INTERMEDIATE AND PROCEDURE FOR THE PREPARATION OF ISOPROPYL-3S-AMINO-2R-HYDROXY ALKANOATES.

SU1341944A1
(en)

1995-02-27

Method of synthesis of 4-quinolone-3-carboxylic acid derivatives

Download PDF in English